Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor

FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake

Fierce Pharma

Tuesday, November 28, 2023 - 11:29pm

tags:

Dermavant, Vtama, psoriasis, Botox

Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators

Fierce Pharma

Tuesday, November 28, 2023 - 11:52am

tags:

Merck, Pfizer, vaccines, clinical trials, pneumococcal disease, V116, Prevnar 20

Roivant ends longshot lupus program after phase 2 fail

Fierce Biotech

Tuesday, November 28, 2023 - 10:32am

tags:

Roivant, lupus, clinical trials, brepocitnib

Novo to expand French plant in GLP-1 production push

BioPharma Dive

Tuesday, November 28, 2023 - 10:30am

tags:

Novo Nordisk, GLP-1 agonist, France, drug manufacturing

BMS, Avidity add another link to cardiovascular partnership with $100M expansion

Fierce Biotech

Tuesday, November 28, 2023 - 10:29am

tags:

Bristol Myers Squibb, Avidity Biosciences, R&D, cardiovascular disease

Sanofi, Regeneron eye Dupixent label expansion with promising COPD data

Medical Marketing and Media

Tuesday, November 28, 2023 - 10:27am

tags:

Sanofi, Regeneron, Dupixent, clinical trials, COPD

Moderna begins work on China mRNA manufacturing site

Reuters

Tuesday, November 28, 2023 - 10:26am

tags:

Moderna Therapeutics, China, MRNA, drug manufacturing

Pharma benefited from basing business overseas. An international tax effort could spur a rethink.

BioPharma Dive

Tuesday, November 28, 2023 - 10:24am

tags:

Bayer, Now Facing Headwinds, Has A History Of Bold Innovation

Forbes

Tuesday, November 28, 2023 - 10:22am

tags:

Bayer, innovation

89bio Unveils Bullish Long-Term Data for NASH Candidate

BioSpace

Tuesday, November 28, 2023 - 10:21am

tags:

89Bio, NASH, clinical trials, pegozafermin

GSK cancer drug Blenrep gets surprise trial win

BioPharma Dive

Tuesday, November 28, 2023 - 10:19am

tags:

GSK, Blenrep, clinical trials, Multiple Myeloma

Boehringer plugs in IBM-trained AI model to boost antibody drug discovery efforts

Fierce Biotech

Tuesday, November 28, 2023 - 10:18am

tags:

Boehringer Ingelheim, artificial intelligence, IBM, machine learnings, drug discovery

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

CP Wire

Wednesday, November 22, 2023 - 12:46pm

tags:

Alzheimer's disease, simulation, drug discovery, SIAM News, Duke University, Penn State University

FDA rebuffs Entrada's attempt to get yearlong hold on DMD drug lifted

Fierce Biotech

Wednesday, November 22, 2023 - 12:03pm

tags:

Entrada Therapeutics, FDA, Duchenne Muscular Dystrophy, ENTR-601-44

This Startup Raised $38 Million To Fill One Of The Biggest Gaps In Drug Discovery

Forbes

Wednesday, November 22, 2023 - 11:56am

tags:

Khosla Ventures, Vivodyne, clinical trials, startups, drug discovery

AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players

Fierce Pharma

Wednesday, November 22, 2023 - 11:39am

tags:

AbbVie, Rinvoq, patents, legal, Sandoz, Sun Pharma, Intas Pharmaceuticals

J&J Seeks Expanded Use of Lung Cancer Drug Rybrevant

Yahoo/Zacks.com

Wednesday, November 22, 2023 - 11:38am

tags:

JNJ, Rybevant, non-small cell lung cancer, AstraZeneca, Tagrisso

Eli Lilly supports Alto Neuroscience in $45m Series C round

Clinical Trials Arena

Wednesday, November 22, 2023 - 11:30am

tags:

Eli Lilly, Alto Neuroscience, funding, psychiatric diesase

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

Tuesday, November 21, 2023 - 10:54pm

tags:

Sanofi, Mylan, legal, FTC, insulin, diabetes

The future's bright for Vetter - from lessons during the pandemic to a brand new facility

Biopharma Reporter

Tuesday, November 21, 2023 - 10:50pm

tags:

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels